Back
Discover Financial Services Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
68
DFS
Discover Financial Services
Last Price:
175.26
Seasonality Move:
1.88%
Buy
100
RYTM
Rhythm Pharmaceuticals
Last Price:
67.31
Seasonality Move:
9.98%
Buy
68
Discover Financial Services (DFS)
is a Buy
Is Discover Financial Services a Buy, Sell or Hold?
- The current Discover Financial Services [DFS] share price is $175.15. The Score for DFS is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- DFS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
100
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $67.33. The Score for RYTM is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
DFS Stock Price Chart
What is Discover Financial Services's stock price today?
-
The Discover Financial Services share price today is $175.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DFS is experiencing slight selling pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $67.33
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
DFS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.61 | Buy |
| Relative Strength Index (14 RSI): | 69.23 | Buy |
| Chaikin Money Flow: | -520469 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (140.49 - 161.35) | Buy |
| Bollinger Bands (100): | (127.72 - 148.44) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.14 | Buy |
| Relative Strength Index (14 RSI): | 81.29 | Buy |
| Chaikin Money Flow: | 966983 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.36 - 56.78) | Buy |
| Bollinger Bands (100): | (43.87 - 52.87) | Buy |
DFS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 160.99 | Buy |
| 20-day SMA: | 152.86 | Buy |
| 50-day SMA: | 143.42 | Buy |
| 200-day SMA: | 129.61 | Buy |
| 8-day EMA: | 164.35 | Buy |
| 20-day EMA: | 155.22 | Buy |
| 50-day EMA: | 146.38 | Buy |
| 200-day EMA: | 130.5 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.18 | Buy |
| 20-day SMA: | 52.43 | Buy |
| 50-day SMA: | 50.91 | Buy |
| 200-day SMA: | 45.07 | Buy |
| 8-day EMA: | 58.59 | Buy |
| 20-day EMA: | 54.14 | Buy |
| 50-day EMA: | 51.2 | Buy |
| 200-day EMA: | 44.61 | Buy |
Discover Financial Services Earnings Growth & DFS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.42 per share, and a decrease next year of $0.98 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.66 per share.
Discover Financial Services Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||